Concepedia
Statistics
Publications
11
Citations
1.3K
H-Index
10
Active since
1997
Affiliations
University of Toronto(Current)
University Health Network
Toronto Western Hospital
Friedrich Miescher Institute
Occupational Cancer Research Centre
Mark H. L. Lambermon is an author at University of Toronto specializing in life sciences, pre-mrna cleavage, and biochemistry.
Publications per year
1997–2008
Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis
JoAnne McLaurin, Roxana Cecal, Meredith E. Kierstead et al. · Nature Medicine · 2002 · 416 citations
Pharmacy, Biochemistry, Pharmacology +12
Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model
JoAnne McLaurin, Meredith E. Kierstead, Mary E. Brown et al. · Nature Medicine · 2006 · 364 citations
Life Sciences, Neuroscience, Pharmacology +17
UBP1, a novel hnRNP‐like protein that functions at multiple steps of higher plant nuclear pre‐mRNA maturation
Mark H. L. Lambermon · The EMBO Journal · 2000 · 110 citations · Full text
Life Sciences, Molecular Biology, Plant Biology +9
SRm160 Splicing Coactivator Promotes Transcript 3′-End Cleavage
Susan McCracken, Mark H. L. Lambermon, Benjamin J. Blencowe · Molecular and Cellular Biology · 2002 · 103 citations · Full text
Life Sciences, Genetics, Molecular Biology +16
Site-Specific Modification of <i>Candida antarctica</i> Lipase B via Residue-Specific Incorporation of a Non-Canonical Amino Acid
Sanne Schoffelen, Mark H. L. Lambermon, Mark B. van Eldijk et al. · Bioconjugate Chemistry · 2008 · 84 citations
Life Sciences, Biochemistry, Biotechnology +15
1–5 of 11